Your browser doesn't support javascript.
loading
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease.
Nishiwaki, Hiroshi; Ito, Mikako; Hamaguchi, Tomonari; Maeda, Tetsuya; Kashihara, Kenichi; Tsuboi, Yoshio; Ueyama, Jun; Yoshida, Takumi; Hanada, Hiroyuki; Takeuchi, Ichiro; Katsuno, Masahisa; Hirayama, Masaaki; Ohno, Kinji.
Afiliação
  • Nishiwaki H; Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ito M; Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hamaguchi T; Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Maeda T; Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.
  • Kashihara K; Department of Neurology, Okayama Kyokuto Hospital, Okayama, Japan.
  • Tsuboi Y; Department of Neurology, Fukuoka University, Fukuoka, Japan.
  • Ueyama J; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yoshida T; Department of Computer Science, Nagoya Institute of Technology, Nagoya, Japan.
  • Hanada H; Center for Advanced Intelligence Project, RIKEN, Tokyo, Japan.
  • Takeuchi I; Department of Computer Science, Nagoya Institute of Technology, Nagoya, Japan.
  • Katsuno M; Center for Advanced Intelligence Project, RIKEN, Tokyo, Japan.
  • Hirayama M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ohno K; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan. hirasan@met.nagoya-u.ac.jp.
NPJ Parkinsons Dis ; 8(1): 65, 2022 Jun 01.
Article em En | MEDLINE | ID: mdl-35650236
To elucidate the relevance of gut dysbiosis in Parkinson's disease (PD) in disease progression, we made random forest models to predict the progression of PD in two years by gut microbiota in 165 PD patients. The area under the receiver operating characteristic curves (AUROCs) of gut microbiota-based models for Hoehn & Yahr (HY) stages 1 and 2 were 0.799 and 0.705, respectively. Similarly, gut microbiota predicted the progression of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III scores in an early stage of PD with AUROC = 0.728. Decreases of short-chain fatty acid-producing genera, Fusicatenibacter, Faecalibacterium, and Blautia, as well as an increase of mucin-degrading genus Akkermansia, predicted accelerated disease progression. The four genera remained unchanged in two years in PD, indicating that the taxonomic changes were not the consequences of disease progression. PD patients with marked gut dysbiosis may thus be destined to progress faster than those without gut dysbiosis.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article